InvestorsHub Logo
Followers 3
Posts 155
Boards Moderated 0
Alias Born 09/24/2018

Re: Meowza post# 292018

Thursday, 08/20/2020 5:02:21 PM

Thursday, August 20, 2020 5:02:21 PM

Post# of 425984
Meowza,

I wasn't intending to make it a business strategy. My post was to show just how unlikely we get to $200 share price. Using a valuation of 20 PE would mean $4 billion in profit. with a 20% net margin (by the way, very high) we would need $20 billion in sales. This without the company increasing their share count and the market giving us the full 20 PE knowing that our current 1 drug will be out of patent protection in the US in 8/9 years.

I believe in 2 years we can get to $5 billion in sales with 20% net margin which would be roughly $2.50/share by 20 PE or $50. For a buyout with a strategic buyer I think we can be bought next year in the 2nd or 3rd quarter for $40 - $50 and they can fold it into their operation with our drug being a complimentary offering with their current lineup.

$200 is cuckoo for cocoa pops
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News